Allianz Asset Management GmbH - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 44 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q1 2020$37,086,000
-35.6%
34,985,000
-33.9%
0.05%
-5.7%
Q4 2019$57,631,000
+5.2%
52,955,0000.0%0.05%
-1.9%
Q3 2019$54,771,000
-8.1%
52,955,0000.0%0.05%
-1.8%
Q2 2019$59,608,000
-1.0%
52,955,0000.0%0.06%
-8.3%
Q1 2019$60,226,000
+4.8%
52,955,000
+2.7%
0.06%
-4.8%
Q4 2018$57,493,000
+62.9%
51,555,000
+75.0%
0.06%
+96.9%
Q3 2018$35,299,000
+19.6%
29,455,000
+15.7%
0.03%
+10.3%
Q2 2018$29,513,000
+4.7%
25,455,0000.0%0.03%
+7.4%
Q1 2018$28,185,000
-22.5%
25,455,000
-16.6%
0.03%
-6.9%
Q4 2017$36,390,000
-9.4%
30,520,000
-8.6%
0.03%
-17.1%
Q3 2017$40,167,000
+3.7%
33,375,000
+1.5%
0.04%
-5.4%
Q2 2017$38,743,000
+217.4%
32,875,000
+219.3%
0.04%
+208.3%
Q1 2017$12,208,000
-0.4%
10,295,0000.0%0.01%
+9.1%
Q4 2016$12,255,000
-46.9%
10,295,000
-44.1%
0.01%
-52.2%
Q3 2016$23,067,000
+6.1%
18,415,000
-3.1%
0.02%0.0%
Q2 2016$21,749,000
-9.6%
18,995,000
-5.7%
0.02%
-17.9%
Q1 2016$24,057,000
+6.4%
20,135,000
+20.0%
0.03%
+7.7%
Q4 2015$22,606,000
+0.4%
16,785,000
-2.6%
0.03%
-3.7%
Q3 2015$22,512,000
-31.5%
17,235,000
-16.9%
0.03%
-22.9%
Q2 2015$32,856,00020,735,0000.04%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q1 2016
NameSharesValueWeighting ↓
Sonora Investment Management, LLC 4,885,000$5,468,0000.79%
ADVENT CAPITAL MANAGEMENT /DE/ 23,153,000$25,858,0000.62%
RWC Asset Management LLP 7,300,000$8,119,0000.42%
IRON Financial LLC 460,000$513,0000.40%
Calamos Advisors LLC 47,578,000$53,058,0000.35%
EDMOND DE ROTHSCHILD HOLDING S.A. 7,175,000$7,979,0000.28%
Calamos Wealth Management LLC 1,370,000$1,528,0000.23%
SSI INVESTMENT MANAGEMENT LLC 1,835,000$2,043,0000.19%
OAKTREE CAPITAL MANAGEMENT LP 13,120,000$14,628,0000.13%
PALISADE CAPITAL MANAGEMENT, LP 3,221,000$3,613,0000.13%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders